Results 221 to 230 of about 790,552 (265)

Ovarian Aging: Mechanisms, Age‐Related Disorders, and Therapeutic Interventions

MedComm, Volume 6, Issue 12, December 2025.
A comprehensive overview of the molecular mechanisms underlying ovarian aging, its association with age‐related diseases, and potential therapeutic interventions. Ovarian aging involves DNA damage, mitochondrial dysfunction, oxidative stress, telomere attrition, and follicular depletion, driving age‐related infertility, menopause, and multiple systemic
Xingyu Liu, Yuanqu Zhao, Yanzhi Feng, Shixuan Wang, Jinjin Zhang   +4 more
wiley   +1 more source

Risk Factors for Postoperative Atrial Fibrillation in Myocardial Revascularization Surgery: A 15-Year Experience. [PDF]

J Clin Med
Bonilla-Bonilla DM, Osorio-Toro LM, Daza-Arana JE, Quintana-Ospina JH, Ávila-Valencia JC, Lozada-Ramos H.   +5 more
europepmc   +1 more source

Red blood cell distribution width as a novel prognostic marker after myocardial revascularization or cardiac valve surgery. [PDF]

Sci Rep, 2021
Lazzeroni D, Moderato L, Marazzi PL, Pellegrino C, Musiari E, Castiglioni P, Camaiora U, Bini M, Geroldi S, Brambilla L, Brambilla V, Coruzzi P.   +11 more
europepmc   +1 more source

Lipoprotein(a), ABO Blood Types and Clinical Outcomes: Novel Findings and Clinical Implications in Patients With Chronic Coronary Syndrome

MedComm, Volume 6, Issue 12, December 2025.
The present study firstly revealed that the predictive value of Lp(a) for worse outcomes in chronic coronary syndrome patients with A or B blood group was stronger than that in the O group, suggesting that ABO blood group measurement may be clinically helpful for decision‐making in Lp(a) intervention. ABSTRACT This study aimed to investigate the effect
Hui‐Hui Liu, Chen‐Xi Song, Sha Li, Yan Zhang, Dong Yin, Wei‐Hua Song, Yuan‐Lin Guo, Cheng‐Gang Zhu, Na‐Qiong Wu, Rui‐Xia Xu, Qian Dong, Jie Qian, Yu‐Hui Zhang, Ke‐Fei Dou, Jian‐Jun Li   +14 more
wiley   +1 more source

The Relationship Between Serum Uric Acid at Different Concentrations of Lipid Indices and the Risk of Myocardial Revascularization in Patients With Acute Coronary Syndrome: A Retrospective Analysis. [PDF]

Front Cardiovasc Med, 2021
Lin Y, Hidru TH, Fan R, Gao J, Li H, Yang X, Xia Y.   +6 more
europepmc   +1 more source

Coping With Chronic Illness: A Systematic Review of Adaptive Strategies Across Cancer, COPD, Diabetes and Heart Disease

Public Health Challenges, Volume 4, Issue 4, December 2025.
This systematic review explores how individuals with cancer, chronic obstructive pulmonary disease (COPD), diabetes and coronary heart disease adapt to the complex challenges posed by chronic illness. The review was designed to identify, categorise and compare coping strategies across these conditions, while also examining how personal experiences ...
Andrew Kweku Conduah, Mary Naana Essiaw, Sebastian Hadjor Ofoe   +2 more
wiley   +1 more source

Frailty as an Independent Predictor of Adverse Outcomes in Patients Undergoing Direct Myocardial Revascularization. [PDF]

Diagnostics (Basel)
Krivoshapova K, Tsygankova D, Bazdyrev E, Barbarash O.   +3 more
europepmc   +1 more source

Effect of Cardiac Rehabilitation on Cardiovascular Events in Patients With Advanced Chronic Kidney Disease

Therapeutic Apheresis and Dialysis, Volume 29, Issue 6, Page 856-865, December 2025.
ABSTRACT Introduction Little is known about the effect of cardiac rehabilitation (CR) on cardiovascular events in patients with advanced chronic kidney disease (CKD). Methods We performed a retrospective cohort study in 189 patients with an estimated glomerular filtration rate of less than 30 mL/min/1.73 m2 who were referred to our outpatient CR center.
Tomoaki Hama, Takatoshi Kakuta, Kazushige Amano, Akiko Ushijima, Fuminobu Yoshimachi, Yuji Ikari   +5 more
wiley   +1 more source

Current indications and surgical strategies for myocardial revascularization in patients with left ventricular dysfunction: a scoping review. [PDF]

J Cardiothorac Surg
Moreno-Angarita A, Peña D, de León JDL, Estacio M, Vila LP, Muñoz MI, Cadavid-Alvear E.   +6 more
europepmc   +1 more source

Repurposing colchicine for reduction of residual inflammatory risk in type 1 diabetes: Design and rationale of the REC1TE trial

Diabetes, Obesity and Metabolism, Volume 27, Issue 12, Page 6884-6893, December 2025.
Abstract Aims Compared to people without diabetes, individuals with type 1 diabetes have a several‐fold increased risk of cardiovascular (CV) morbidity and mortality despite guideline‐recommended management of traditional risk factors; so‐called residual CV risk.
David S. Mathiesen, Josefine V. Hansen, Aske Høck, Casper K. Nielsen, Miriam G. Pedersen, Peter L. Kristensen, Henrik U. Andersen, Marie Louise Aarestrup, Julie L. Forman, Jonatan I. Bagger, Thomas F. Dejgaard, Filip K. Knop, Nicklas J. Johansen, Asger B. Lund   +13 more
wiley   +1 more source